Riskpilot← Back to searchSign inGet full accessMEDICAE CONSILIOSA AS
ASActiveOrg 998166977Skulebakken 9, 5355 KnarrevikGeneral medical practice activities · NACE 8621Est. 20123 employees
Revenue 2024
NOK 3,7M
-22% vs 2023
EBITDA margin
36.5%
-30% vs 2023
Equity ratio
55.5%
Financial strength
Net profit 2024
NOK 1,4M
-9% vs 2023
| Revenue | NOK 3,7M | -22% |
| EBITDA | NOK 1,4M | -30% |
| Net profit | NOK 1,4M | -9% |
| Total assets | NOK 4,1M | +31% |
| Equity | NOK 2,3M | +64% |
| Employees | 3 | — |
Legal name
MEDICAE CONSILIOSA AS
Org number
998166977
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
2. april 2012
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Tilby legetjenester, og andre helsetjenester knyttet til legevirksomheten.
Address
Skulebakken 9, 5355 Knarrevik
Phone
+4755318307
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 661 | 4 441 | 4 068 | 4 780 | 3 749 |
| Staff expenses | −1 255 | −1 066 | −1 000 | −1 140 | −981 |
| EBITDA | 935 | 1 747 | 1 538 | 1 949 | 1 368 |
| Depreciation & amort. | −207 | −87 | −56 | −55 | −50 |
| EBIT | 729 | 1 659 | 1 482 | 1 894 | 1 317 |
| Net financials | 4 | −0 | 5 | 35 | 358 |
| Profit before tax | 733 | 1 659 | 1 487 | 1 930 | 1 675 |
| Tax | 172 | 360 | 321 | 424 | 299 |
| Net profit | 560 | 1 299 | 1 166 | 1 505 | 1 376 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 419 | 2 474 | 2 647 | 3 092 | 4 062 |
| Equity | 307 | 405 | 1 071 | 1 376 | 2 252 |
| Long-term debt | 0 | 0 | 5 | 13 | 16 |
| Short-term debt | 1 112 | 2 069 | 1 571 | 1 702 | 1 793 |
| Total debt | 1 112 | 2 069 | 1 576 | 1 716 | 1 809 |
EBITDA margin
36.5%
This company
15.8%
Market median
+131% vs market
20202024
Equity ratio
55.5%
This company
38.2%
Market median
+45% vs market
20202024
Return on equity
61.1%
This company
18.4%
Market median
+232% vs market
20202024
Net profit margin
36.7%
This company
8.1%
Market median
+353% vs market
20202024
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TL Chief Executive Officer | Chief Executive Officer | 2012 |
KR Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDICAE CONSILIOSA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Toril Lømsland | Chief Executive Officer | 0 companies |
| Ketil Reinert Petersen Lømsland | Deputy Member | 0 companies |
| Filip Emil Bagøien Johnsen Lømsland | Board of Directors | 0 companies |